Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center
Xconomy
APRIL 29, 2019
That company was Syrrx, a private San Diego-based biotech that used X-ray crystallography to help determine the structures of disease-related molecules so drugs could be designed to target them. More than 90 percent of them are researchers. The site is one of three the company has worldwide: Its other research centers.
Let's personalize your content